23/10/2006 (Agence Europe) - On Monday 23 October, the Council of Ministers in Luxembourg formally adopted the new regulation on medicinal products for paediatric use. On the basis of the agreement reached with the European Parliament, the main obligation is that a paediatric investigation plan must be submitted as part of the procedure for obtaining market authorisation, while incentives are provided through the extension of exclusive rights and the introduction of a new type of market...